Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wramsby, M.L.
Right arrow Articles by Bremme, A.K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wramsby, M.L.
Right arrow Articles by Bremme, A.K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 15, No. 4, 795-797, April 2000
© 2000 European Society of Human Reproduction and Embryology

Response to activated protein C during normal menstrual cycle and ovarian stimulation

M.L. Wramsby1,5, M.I. Bokarewa2,4, M. Blombäck3 and A.K. Bremme1

1 Department of Women and Child Health, Box 140, 2 Department of Laboratory Medicine/Coagulation Research, 3 Department of Laboratory Medicine/Coagulation Research, Karolinska Institutet, 171 76 Stockholm and 4 Department of Rheumatology,Sahlgren's Hospital, 413 45 Gothenburg, Sweden

Oestrogen has been pointed out as a pre-thrombotic factor. Protein C is a key enzyme in the down-regulation of blood coagulation. Recent data suggest that activated protein C (APC) resistance which is not due to the factor V:Q 506 Leiden mutation and appears to be acquired, is also a risk factor for thrombosis. In this study, we evaluated the endogenous oestradiol production and its possible influence on APC. Eighteen normally menstruating women were studied during one ovulatory cycle. Furthermore, 20 women undergoing controlled ovarian stimulation, and achieving extremely high oestradiol concentrations, were investigated. Normalized APC (nAPC) ratio (clotting time of tested sample/clotting time of pooled control plasma) was measured. Samples collected on menstrual cycle days 1–3, 6–8, 13–14, 20–24 corresponded to nAPC ratios 1.02 ± 0.19 (mean ± SD), 1.05 ± 0.15, 1.02 ± 0.16 and 1.03 ± 0.21 respectively. During ovarian stimulation, the nAPC ratios were 0.99 ± 0.12, 1.03 ± 0.18, 1.01 ± 0.16 and 0.97 ± 0.13 at oestradiol minimum, days 5–8 pre-oocyte retrieval, oestradiol maximum and at oocyte retrieval respectively. In spite of the great difference in the concentrations of oestradiol between women in normal menstrual cycle and women undergoing ovarian stimulation, no difference in nAPC ratios was observed.

Key words: APC resistance/menstrual cycle/ovarian stimulation

5 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
G. Ricci, F. Cerneca, R. Simeone, C. Pozzobon, S. Guarnieri, A. Sartore, R. Pregazzi, and S. Guaschino
Impact of highly purified urinary FSH and recombinant FSH on haemostasis: an open-label, randomized, controlled trial
Hum. Reprod., April 1, 2004; 19(4): 838 - 848.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. W. F. T. Toorians, M. C. L. G. D. Thomassen, S. Zweegman, E. J. P. Magdeleyns, G. Tans, L. J. G. Gooren, and J. Rosing
Venous Thrombosis and Changes of Hemostatic Variables during Cross-Sex Hormone Treatment in Transsexual People
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5723 - 5729.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.